W Fiskus, S Boettcher, N Daver,
CP Mill,
K Sasaki… - Blood cancer …, 2022 - nature.com
Abstract Treatment with Menin inhibitor (MI) disrupts the interaction between Menin and
MLL1 or MLL1-fusion protein (FP), inhibits HOXA9/MEIS1, induces differentiation and loss of …